INM (INM) Stock Price & Analysis
INM (INM) fell 0.72% to USD 1.37 as of September 8, 2026 at 17:55 UTC, according to Nexqual real-time market data.
INM last closed at USD 1.37; the session ranged USD 1.36–1.39 on volume of 9,868 shares. Market capitalization is —, with a 52-week range of USD 0.58–2.5 (NCM). Source: Nexqual, September 8, 2026 at 17:55 UTC.
Key Statistics (as of September 8, 2026 at 17:55 UTC)
| Price | USD 1.37 |
|---|---|
| Change | ▼ 0.72% (down) |
| Previous Close | USD 1.37 |
| Open | USD 1.37 |
| Day Range | USD 1.36 – 1.39 |
| 52-Week Range | USD 0.58 – 2.5 |
| Volume | 9,868 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (INM)
Nexqual's technical model rates INM "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 17:55 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 41.12 (neutral) |
| vs SMA50 | Below (USD 1.52) |
| MACD | -0.04 (negative) |
From INM's Latest SEC 10-K Filing (filed 2025-09-23)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ENSC | Ensysce Biosciences, Inc. | USD 0.48 | ▲ 10.2% |
| NUWE | Nuwellis, Inc. | USD 0.8 | ▲ 10.01% |
| QNRX | Quoin Pharmaceuticals, Ltd. | USD 7.21 | ▼ 8.39% |
| SPRC | SciSparc Ltd. | USD 5.15 | ▲ 0.39% |
| REVB | Revelation Biosciences, Inc. | USD 1.04 | ▲ 2.97% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 17:55 UTC. This page is informational and not investment advice.